N

Nicholas G. Fox

Merck & Co., Inc., Rahway, NJ, USA (United States)

2 papers and 6 citations.

2Publications

6Total Citations

Top publicationsby citations

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling

Nadine Álvarez, David S. Perlin, Matthew Zimmerman et al.|Viruses|2024

Cited by 5

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological Profiling

Nadine Álvarez, David S. Perlin, Gregory C. Adam et al.|Preprints.org|2024

Cited by 1

Indexing the rest of 2 publications…